CD44 and glioblastoma: However, the analysis of SEC-enriched serum-derived EVs from HV showed significantly lower CD44 levels compared to EVs from the serum of glioblastoma patients, indicating that CD44-positive EVs are enriched and highly relevant in glioblastoma patients [18].